AChE inhibitors such as tacrine, donepezil, and rivastigmine are commonly used synthetic drugs for the treatment of Alzheimer's disease; however, these drugs are limited in use due to their adverse side effects. This evidence concerns the gene ACHE and Alzheimer disease.